Intercept Pharmaceuticals Announces Public Offering of Convertible Senior Notes

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/16/2026

1. NVDA
2. CRWV
3. SPY
4. BAC
5. VRNS
6. FMC
7. RKLB
8. BLK
9. CAT
10. AA

Go back to Intercept Pharmaceuticals Announces Public Offering of Convertible Senior Notes

Intercept Pharma (ICPT) Prices Aggregate $400M Conv. Notes Offering

June 30, 2016 9:18 AM EDT

Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT) announced the pricing of its previously announced underwritten public offering of $400 million aggregate principal amount of 3.25% convertible senior notes due 2023 (the notes). Intercept has granted the underwriters an option, exercisable for 30 days, to purchase up to an additional $60 million aggregate principal amount of notes on the same terms and conditions, solely to cover over-allotments. The offering is expected to close on or about July 6, 2016, subject to customary closing conditions.

The notes will be senior unsecured obligations of Intercept. The notes will bear interest at a rate of 3.25% per... More